On 6 June 2016
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 6 June 2016, to consider and approve the allotment of 14,50,000 Equity Shares on conversion of remaining 14,50,000 Share Warrants which were allotted on preferential basis to JB Pharma LLP, (Promoter'' or Proposed Allottee) on September 28, 2015 and the issue of which was approved by the shareholders at 42nd Annual General Meeting of the Company held on September 03, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations.Powered by Capital Market - Live News